Ivermectina Teva (Ivermectin)

Ivermectin binds to glutamate‑gated chloride channels that are present in the nerve and muscle cells of many invertebrates. This binding opens the channels, allowing an influx of chloride ions, which hyperpolarizes the cells, leading to paralysis and death of the parasite. Human cells lack these specific channels, which contributes to the drug’s selective toxicity.

The dosage of Ivermectina Teva is determined by the prescribing clinician based on the specific indication, patient weight, age, and clinical condition. Healthcare providers follow established guidelines and adjust the regimen as needed for optimal efficacy and safety.

Safety data for ivermectin in pregnancy and lactation are limited. The drug should only be used when the potential benefit justifies any possible risk to the fetus or infant. Clinicians should discuss individual circumstances with patients and consider alternative therapies when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Ivermectin offers a broad spectrum of activity against many nematodes and ectoparasites, often with a single oral dose, which can be advantageous over drugs that require multiple administrations. Compared with alternatives such as albendazole or permethrin, ivermectin may have a different safety profile and specific efficacy for conditions like onchocerciasis and strongyloidiasis.

Ivermectina Teva should be stored at room temperature below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Ivermectina Teva is taken orally, usually with water. The exact administration schedule—whether a single dose or a repeat dose—depends on the indication and the prescriber’s instructions. Patients should follow the healthcare professional’s guidance regarding timing and any required fasting.

Serious adverse events, though rare, can include severe skin reactions such as Stevens‑Johnson syndrome, hepatic injury, neurologic toxicity (e.g., seizures or altered mental status), and anaphylaxis. Patients should seek immediate medical attention if they experience rash, jaundice, neurological symptoms, or signs of an allergic reaction.

Ivermectina Teva is contraindicated in individuals with a known hypersensitivity to ivermectin or any of its excipients. Caution is also advised for patients with severe hepatic impairment, certain neurological disorders, or those taking medications that strongly inhibit CYP3A4 or P‑gp without appropriate monitoring.